Business · 15/03/2004Updated: 10/17/2026 · 1 min read
FDA Report on Postmarketing Commitment Studies for Drug and Biologics Firms
Summary
The Food and Drug Administration (FDA) is required to annually report on the status of postmarketing study commitments made by drug and biologics sponsors, as mandated by the Food and Drug Administration Modernization Act of 1997.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →